Skip to main content

Table 5 Incidence and clearance of anal HPV infections

From: The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature

Author (ref) Population, age (yrs) Incidence (per 100py) Clearance
   Any HPV HR 16 18 Type of Infection Unit of clearance Any HPV HR 16 18
Males            
de Pokomandy [38] HIV + ve MSM, 21–66 - - 13.0
(9.6–17.6)
5.3
(3.5–8.0)
Prevalent Per 100py    14.6
(10.2–21.2)
24.5
(16.9–35.4)
Nyitray [35] MSM, 18–70
MSW, 18–70
31.1 (TS)
(16.6–53.2)
9.7
(7.2–12.8)
25.4
(14.5–41.2)
4.4
(2.9–6.6)
5.8
(1.9–13.4)
0.8
(0.2–2.0)
4.6
(1.2–11.6)
1.1
(0.4–2.3)
Prevalent % at 6 m- 57.1 (TS)
(50.1–63.8)
70.9
(63.5–77.5)
55.8
(44.1–67.2)
77.5
(66.0–86.5)
27.2
(6.0–61.0)
100
(83.9–100)
62.5
(24.5–91.5)
100
(15.8–100)
Videla [23] HIV + ve MSM, 20- > 69
HIV + ve MSW, 20- > 69
32.4 (NTS)
(23.3–43.7)
7.9
(4.9–15.7)
- - - Prevalent Per 100py 12.6 (NTS)
(10.2–15.2)
18.4
(12.2–26.5)
- - -
Darwich [20] HIV + ve MSM, 20- > 69
HIV + ve MSW, 20- > 69
- - 7.1
(5.5–9.5)
5.3
(3.0–8.6)
3.6
(3.5–5.2)
0.4
(0.1–1.8)
Prevalent Per 100py -   22.4
(17.6–28.1)
18.6
(7.4–38.2)
31.0
(20.3–45.4)
30.0
(7.8–76.8)
Mullins [37] HIV-ve, 12–18
HIV + ve, 12–18
24 (NTS, first)
(11–52)
40
(27–61)
11
(3.4–33)
27
(17–44)
- - - - - - - -
Glick [33] MSM, 16–30 46.2 (NTS, unclear)
(45.6–46.9)
36.7
(36.2–37.3)
12.4
(12.1–12.6)
5.5
(5.3–5.6)
Prevalent % at 1 year 81.3 (TS)
(67.4–91.1)
66.7
(49.0–81.4)
50.0
(26.0–74.0)
66.7
(22.3–95.7)
Hernandez [34] HIV + ve MSM, mean 45 21.3 (TS, total)
(17.7–25.4)
13.3
(10.5–16.6)
3.5
(1.8–6.1)
3.7
(2.1–6.1)
- - - - - -
Females            
Goodman [36], Shvetsov [39] Sexually active women, 18–44 56.3 (NTS, first)
(48.5–65.0)
23.4
(19.2–28.3)
3.0
(1.8–4.8)
2.3
(1.2–3.9)
Incident Per 100py 89.3 (TS)
(67.8–115.4)
109.9
(83.3–142.4)
141.2
(73.0–246.7)
130.0
(47.6–282.8)
Moscicki [40] Sexually active women, 13–21 - - - - Prevalent % at 12 m - 29.7 (TS 2 + neg)
(19.0–41.7)
45.0
(27.2–62.1)
55.6
(21.2–86.3)
Mullins [37] HIV-ve women, 12–18
HIV + ve women, 12–18
14 (NTS,first)
(9.2–22)
30
(24–38)
5.3
(2.6–11)
12
(8.4–16)
- - - - - - - -
  1. Abbreviations: MSM men who have sex with men, MSW men who have sex with women, py person-years, TS type-specific incidence defined as at least one positive test for any HPV type or HR-HPV type not detected at baseline, NTS non-type-specific incidence defined as at least one positive test for any HPV type or HR-HPV type among those negative for any HPV DNA or any HR-HPV DNA at baseline